BMC Endocrine Disorders

tracked for impact factor

Open Access Highly Access Email this article to a friend

Safety and tolerability of sitagliptin in clinical studies: a pooled analysis of data from 10,246 patients with type 2 diabetes

Debora Williams-Herman*, Samuel S Engel, Elizabeth Round, Jeremy Johnson, Gregory T Golm, Hua Guo, Bret J Musser, Michael J Davies, Keith D Kaufman and Barry J Goldstein

BMC Endocrine Disorders 2010, 10:7 doi:10.1186/1472-6823-10-7

Fields marked * are required


Multiple email addresses should be separated with commas or semicolons.